Community-Acquired Pneumonia with Dr. Anna Thorner
Community-acquired pneumonia is one of the most commonly encountered infections in the hospital setting. In this interview, Dr. Anna Thorner discusses the basics of diagnosing and treating pneumonia as well as delving into the roles of procalcitonin and glucocorticoids in its management.
00:00 introduction 03:03 a case and differential diagnosis 06:05 procalcitonin 10:16 a second case and first line inpatient treatments 14:04 causative pathogens 18:22 testing for a causative pathogen 23:18 “healthcare-associated pneumonia” and drug-resistance 29:39 MRSA and Pseudomonas 34:46 duration and de-escalation of therapy 36:48 glucocorticoids for pneumonia 40:32 summary and concluding remarks 45:13 credits
This podcast is part of the series, Curbside Consults, which complements the foundational information in Rotation Prep by taking a deep dive into key topics with expert clinicians and educators. As we explore the details of pathophysiology and critique the evidence behind clinical practice, these conversations are intended to give you better understanding of the topic and greater confidence when treating your patients.
Dr. Thorner is an Associate Physician in the Division of Infectious Diseases at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Assistant Professor at Harvard Medical School, and Deputy Editor of Infectious Diseases and Co-Director of Editorial Projects at UpToDate/Wolters Kluwer Health.
Mike Mi is a 2017-2018 NEJM Editorial Fellow and a hospitalist at Beth Israel Deaconess Medical Center. He graduated from Harvard Medical School and completed his internal medicine training at BIDMC.